F-18 FDG uptake of bone marrow on PET/CT scan: It's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 81-87

  Ak, Ilknur ^b   Gulbas, Zafer ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE

Author keywords

CD38 CD138; F FDG; Multiple myeloma; PET CT; Plasma cells

Indexed keywords

BETA 2 MICROGLOBULIN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; MELPHALAN; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SERUM ALBUMIN; SYNDECAN 1; VINCRISTINE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CANCER RELAPSE; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG MEGADOSE; DRUG UPTAKE; DRUG USE; FEMALE; FEMUR; FLOW CYTOMETRY; HUMAN; MALE; MEAN STANDARDIZED UPTAKE VALUE; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; BONE MARROW; BONE MARROW CELLS; CELL COUNT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POSITRON-EMISSION TOMOGRAPHY; SYNDECAN-1; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 78651344109     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1037-7     Document Type: Article

References (38)

1. C Nanni E Zamagni M Farsad, et al. 2006 Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results Eur J Nucl Med Mol Imaging 33 525 531 10.1007/s00259-005-0004-3 16453155
2. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics CA Cancer J Clin 49 1 8 31 1:STN:280:DyaK1M3hs1OrsA%3D%3D 10.3322/canjclin.49.1.8 10200775
3. M Beksaç M Delforge P Richardson 2008 The evolving treatment paradigm of multiple myeloma: from past to present and future Turk J Hematol 25 2 60 70
4. SV Rajkumar RA Kyle 2005 Multiple myeloma: diagnosis and treatment Mayo Clin Proc 80 1371 1382 10.4065/80.10.1371 16212152
5. A Rawstron R Owen F Davies, et al. 1997 Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage Br J Haematol 97 46 55 1:STN:280:DyaK2s3ot1KgsA%3D%3D 10.1046/j.1365-2141.1997.72653. x 9136941
6. T Tedder L Clement M Cooper 1984 Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation Tissue Antigens 24 140 149 1:CAS:528:DyaL2MXit1GitA%3D%3D 10.1111/j.1399-0039.1984.tb02118.x 6440308
7. M Chilosi F Adami M Lestani L Montagna L Cimarosto G Semenzato G Pizzolo F Menestrina 1999 CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies Mod Pathol 12 1101 1106 1:STN:280:DC%2BD3c%2FosVakuw%3D%3D 10619261
8. M Dhodapkar R Sanderson 1999 Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behaviour within the tumor microenvironment Leuk Lymphoma 34 35 43 1:CAS:528:DC%2BD3cXlsFSks70%3D 10350330
9. I Ak V Aslan E Vardareli Z Gülbaş 2003 Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells Ann Hematol 82 2 88 92 1:CAS:528:DC%2BD3sXhsV2mu7g%3D 10.1007/s00277-002-0600-2 12601486 (Pubitemid 36700981)
10. CJ Hanrahan CR Christensen JR Crim 2010 Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT Radiographics 30 1 127 142 10.1148/rg.301095066 20083590
11. TB Bartel J Haessler TL Brown, et al. 2009 F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma Blood 14 10 2068 2076 10.1182/blood-2009-03-213280
12. CP Shortt TG Gleeson KA Breen J McHugh MJ O'Connell PJ O'Gorman SJ Eustace 2009 Whole-body MRI versus PET in assessment of multiple myeloma disease activity AJR Am J Roentgenol 92 4 980 986 10.2214/AJR.08.1633
13. J Hur CS Yoon YH Ryu MJ Yun JS Suh 2008 Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma Acta Radiol 49 4 427 435 1:STN:280:DC%2BD1c3lsVGltQ%3D%3D 10.1080/02841850801898625 18415787 (Pubitemid 351598798)
14. Ak Sivrikoz İ, Üsküdar Teke H, Gülbaş Z (2010). Spinal cord involvement of multiple myeloma detected by F-18 FDG PET/CT scan. Turk J Hematol 27(4) (in press)
15. L Pace L Catalano S Del Vecchio, et al. 2001 Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up Eur J Nucl Med Mol Imaging 28 304 312 1:CAS:528: DC%2BD3MXitFeiurY%3D 10.1007/s002590000440
16. MG Alexandrakis DS Kyriakou FH Passam, et al. 2002 Correlation between the uptake of Tc-99m sestamibi and prognostic factors in patients with multiple myeloma Clin Lab Haem 24 155 159 1:STN:280:DC%2BD38zisFShtw%3D%3D 10.1046/j.1365-2257.2002.00201.x (Pubitemid 34639342)
17. G Villa E Balleari M Carletto, et al. 2005 Staging and therapy monitoring of multiple myeloma by 99m-Tc sestamibi scintigraphy: a 5 year single center experience J Exp Clin Cancer Res 24 355 361 1:STN:280:DC%2BD2MrptFOkug%3D%3D 16270521
18. A Mele M Offidani G Visani, et al. 2007 Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and follow up of patients with multiple myeloma: a multicentre study on 397 scans Br J Haematol 36 729 735 10.1111/j.1365-2141.2006.06489.x
19. N Erten B Saka K Berberoglu, et al. 2007 Technetium-99m 2-methoxy-isobutylisonitrile uptake scintigraphy in detection of bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors Ann Haematol 86 805 813 1:CAS:528:DC%2BD2sXhtV2msbjJ 10.1007/s00277-007-0329-z (Pubitemid 47497099)
20. L Pace L Catalano A Pinto, et al. 1998 Different patterns of technetium-99m sestamibi in multiple myeloma Eur J Nucl Med Mol Imaging 25 714 720 1:CAS:528:DyaK1cXktlyju7k%3D 10.1007/s002590050274 (Pubitemid 28377034)
21. L Delmon-Moingeon D Piwnica-Worms A Van den Abbeele L Holman A Davidson A Jones 1990 Uptake of cation hexakis (2-methoxyisobutylisonitrile)-technetium- 99m by human carcinoma cell line in vitro Cancer Res 50 2198 2202 1:CAS:528:DyaK3cXitFeitbk%3D 2317808
22. D Piwnica-Worms J Kronauge M Chiu 1990 Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence Circulation 82 1826 1838 1:CAS:528:DyaK3MXhsFKmsLk%3D 2225379
23. X Wang S Koch 2009 Positron emission tomography/computed tomography potential pitfalls and artifacts Curr Probl Diagn Radiol 38 4 156 169 10.1067/j.cpradiol.2008.01.001 19464586 Review
24. MA Bredella L Steinbach G Caputo, et al. 2005 Value of FDG PET in the assessment of patients with multiple myeloma Am J Roentgeno 184 1199 1204
25. H Jadvar PS Conti 2002 Diagnostic utility of FDG PET in multiple myeloma Skeletal Radiol 31 690 694 10.1007/s00256-002-0580-2 12483429 (Pubitemid 36104567)
26. BG Durie AD Waxman A D'Agnolo CM Williams 2002 Whole-body (18)F-FDG PET identifies high-risk myeloma J Nucl Med 43 11 1457 1463 12411548
27. H Schirrmeister AK Buck L Bergmann SN Reske M Bommer 2003 Positron emission tomography (PET) for staging of solitary plasmacytoma Cancer Biother Radiopharm 18 5 841 845 10.1089/108497803770418382 14629832
28. GU Hung CC Tsai SC Tsai WY Lin 2005 Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma Anticancer Res 25 6C 4737 4741 16334169
29. L Mileshkin R Blum JF Seymour A Patrikeos RJ Hicks HM Prince 2004 A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma Eur J Haematol 72 1 32 37 1:STN:280:DC%2BD2c%2FntlKmtQ%3D%3D 10.1046/j.0902-4441.2004.00177.x 14962260 (Pubitemid 38161110)
30. I Ak Sivrikoz Z Zafer Gülbaş 2008 A rare presentation of multiple myeloma: Tc-99m MIBI SPECT imaging of orbital involvement Turk J Hematol 25 4 212 213
31. S Lütje JW de Rooy S Croockewit E Koedam WJ Oyen RA Raymakers 2009 Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma Ann Hematol 88 12 1161 1168 10.1007/s00277-009-0829-0 19763570 Review
32. PJ Kim RJ Hicks A Wirth G Ryan JF Seymour HM Prince MP Mac Manus 2009 Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma Int J Radiat Oncol Biol Phys 74 3 740 746 1:CAS:528:DC%2BD1MXmsFyiu7c%3D 10.1016/j.ijrobp.2008.08.037 19038505
33. SB Chiang A Rebenstock L Guan A Alavi H Zhuang 2003 Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging Clin Nucl Med 28 674 676 10.1097/00003072-200308000- 00014 12897658 (Pubitemid 38281902)
34. A Takalkar JQ Yu R Kumar Y Xiu A Alavi H Zhuang 2004 Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography Clin Nucl Med 29 637 639 10.1097/00003072-200410000-00010 15365439 (Pubitemid 40228171)
35. Y Sugawara SJ Fisher KR Zasadny PV Kison LH Baker RL Wahl 1998 Preclinical and clinical studies of bone marrow uptake of fluorine-18- fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy J Clin Oncol 16 173 180 1:CAS:528:DyaK1cXmtlOksQ%3D%3D 9440740
36. WJ Yao CK Hoh RA Hawkins JA Glapsy JA Weil SJ Lee 1995 Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines J Nucl Med 36 794 799 1:STN:280:DyaK2M3ls12ksA%3D%3D 7738650
37. S Gundlapalli B Ojha JM Mountz 2002 Granulocyte colony-stimulating factor confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma Clin Nucl Med 27 140 141 10.1097/00003072-200202000-00018 11786751 (Pubitemid 34075881)
38. MV Knopp H Bischoff A Rimac F Oberdorfer G van Kaick 1996 Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation Nucl Med Biol 23 845 849 1:CAS:528: DyaK28XmsFWmur0%3D 10.1016/0969-8051(96)00085-6 8940729 (Pubitemid 26342490)